Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations

[...]case: 66-year-old woman, stage IV colon adenocarcinoma, FOLFOX treatment. [...]we describe an important number of confirmed HSRs to leucovorin during a 1-year period.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2015-04, Vol.135 (4), p.1066-1067
Hauptverfasser: Ureña-Tavera, Alicia, MD, Zamora-Verduga, Miriam, MD, Madrigal-Burgaleta, Ricardo, MD, Angel-Pereira, Denisse, MD, Berges-Gimeno, Maria Pilar, MD, PhD, Alvarez-Cuesta, Emilio, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1067
container_issue 4
container_start_page 1066
container_title Journal of allergy and clinical immunology
container_volume 135
creator Ureña-Tavera, Alicia, MD
Zamora-Verduga, Miriam, MD
Madrigal-Burgaleta, Ricardo, MD
Angel-Pereira, Denisse, MD
Berges-Gimeno, Maria Pilar, MD, PhD
Alvarez-Cuesta, Emilio, MD, PhD
description [...]case: 66-year-old woman, stage IV colon adenocarcinoma, FOLFOX treatment. [...]we describe an important number of confirmed HSRs to leucovorin during a 1-year period.
doi_str_mv 10.1016/j.jaci.2014.09.045
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1668313601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0091674914014316</els_id><sourcerecordid>3643025871</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-98aa49171637cde589bb72eec585645d55cb4498bfb8af085e4b26371b334dd23</originalsourceid><addsrcrecordid>eNp9kV-L1DAUxYMo7rj6BXyQgC_60Jq0SdqACLI47sDAgH_At5Amt27GaTObpAP105vurAo--HRv4JwT7u8g9JySkhIq3uzLvTaurAhlJZElYfwBWlEim0K0FX-IVoRIWoiGyQv0JMY9ye-6lY_RRcUZb6QUK_Tzej5CiDBGl9zJpRkH0CY5P0acPA7awOAMNvpg3DTg3h_cqBPgVweYjD_54MbX2E55fMfr3Xa9-4b1aO_WzacNNjcw-HQDQR9nrO3gRhdT0Hf5T9GjXh8iPLufl-jr-sOXq-tiu_u4uXq_LQwjIhWy1ZpJ2lBRN8YCb2XXNRWA4S0XjFvOTceYbLu-a3VPWg6sq7KWdnXNrK3qS_TynHsM_naCmNTeT2HMXyoqRFvTWhCaVdVZZYKPMUCvjsENOsyKErXgVnu14FYLbkWkyriz6cV99NQNYP9YfvPNgrdnAeQDTw6CisbBaMC6ACYp693_89_9YzeZv8tt_IAZ4t87VKwUUZ-Xwpe-KcshdSb2C1aqpvM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1668313601</pqid></control><display><type>article</type><title>Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ureña-Tavera, Alicia, MD ; Zamora-Verduga, Miriam, MD ; Madrigal-Burgaleta, Ricardo, MD ; Angel-Pereira, Denisse, MD ; Berges-Gimeno, Maria Pilar, MD, PhD ; Alvarez-Cuesta, Emilio, MD, PhD</creator><creatorcontrib>Ureña-Tavera, Alicia, MD ; Zamora-Verduga, Miriam, MD ; Madrigal-Burgaleta, Ricardo, MD ; Angel-Pereira, Denisse, MD ; Berges-Gimeno, Maria Pilar, MD, PhD ; Alvarez-Cuesta, Emilio, MD, PhD</creatorcontrib><description>[...]case: 66-year-old woman, stage IV colon adenocarcinoma, FOLFOX treatment. [...]we describe an important number of confirmed HSRs to leucovorin during a 1-year period.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2014.09.045</identifier><identifier>PMID: 25457996</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acids ; Aged ; Aged, 80 and over ; Allergy and Immunology ; Antineoplastic Combined Chemotherapy Protocols - adverse effects ; Back pain ; Calcium ; Camptothecin - adverse effects ; Camptothecin - analogs &amp; derivatives ; Chemotherapy ; Colorectal cancer ; Drug dosages ; Drug Hypersensitivity - diagnosis ; Drug Hypersensitivity - immunology ; Female ; Fluorouracil - adverse effects ; Humans ; Leucovorin - administration &amp; dosage ; Leucovorin - adverse effects ; Male ; Medical treatment ; Neoplasms - complications ; Neoplasms - drug therapy ; Organoplatinum Compounds - adverse effects ; Vitamin B</subject><ispartof>Journal of allergy and clinical immunology, 2015-04, Vol.135 (4), p.1066-1067</ispartof><rights>American Academy of Allergy, Asthma &amp; Immunology</rights><rights>2014 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright Elsevier Limited Apr 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-98aa49171637cde589bb72eec585645d55cb4498bfb8af085e4b26371b334dd23</citedby><cites>FETCH-LOGICAL-c406t-98aa49171637cde589bb72eec585645d55cb4498bfb8af085e4b26371b334dd23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2014.09.045$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25457996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ureña-Tavera, Alicia, MD</creatorcontrib><creatorcontrib>Zamora-Verduga, Miriam, MD</creatorcontrib><creatorcontrib>Madrigal-Burgaleta, Ricardo, MD</creatorcontrib><creatorcontrib>Angel-Pereira, Denisse, MD</creatorcontrib><creatorcontrib>Berges-Gimeno, Maria Pilar, MD, PhD</creatorcontrib><creatorcontrib>Alvarez-Cuesta, Emilio, MD, PhD</creatorcontrib><title>Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>[...]case: 66-year-old woman, stage IV colon adenocarcinoma, FOLFOX treatment. [...]we describe an important number of confirmed HSRs to leucovorin during a 1-year period.</description><subject>Acids</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Allergy and Immunology</subject><subject>Antineoplastic Combined Chemotherapy Protocols - adverse effects</subject><subject>Back pain</subject><subject>Calcium</subject><subject>Camptothecin - adverse effects</subject><subject>Camptothecin - analogs &amp; derivatives</subject><subject>Chemotherapy</subject><subject>Colorectal cancer</subject><subject>Drug dosages</subject><subject>Drug Hypersensitivity - diagnosis</subject><subject>Drug Hypersensitivity - immunology</subject><subject>Female</subject><subject>Fluorouracil - adverse effects</subject><subject>Humans</subject><subject>Leucovorin - administration &amp; dosage</subject><subject>Leucovorin - adverse effects</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Neoplasms - complications</subject><subject>Neoplasms - drug therapy</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Vitamin B</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV-L1DAUxYMo7rj6BXyQgC_60Jq0SdqACLI47sDAgH_At5Amt27GaTObpAP105vurAo--HRv4JwT7u8g9JySkhIq3uzLvTaurAhlJZElYfwBWlEim0K0FX-IVoRIWoiGyQv0JMY9ye-6lY_RRcUZb6QUK_Tzej5CiDBGl9zJpRkH0CY5P0acPA7awOAMNvpg3DTg3h_cqBPgVweYjD_54MbX2E55fMfr3Xa9-4b1aO_WzacNNjcw-HQDQR9nrO3gRhdT0Hf5T9GjXh8iPLufl-jr-sOXq-tiu_u4uXq_LQwjIhWy1ZpJ2lBRN8YCb2XXNRWA4S0XjFvOTceYbLu-a3VPWg6sq7KWdnXNrK3qS_TynHsM_naCmNTeT2HMXyoqRFvTWhCaVdVZZYKPMUCvjsENOsyKErXgVnu14FYLbkWkyriz6cV99NQNYP9YfvPNgrdnAeQDTw6CisbBaMC6ACYp693_89_9YzeZv8tt_IAZ4t87VKwUUZ-Xwpe-KcshdSb2C1aqpvM</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Ureña-Tavera, Alicia, MD</creator><creator>Zamora-Verduga, Miriam, MD</creator><creator>Madrigal-Burgaleta, Ricardo, MD</creator><creator>Angel-Pereira, Denisse, MD</creator><creator>Berges-Gimeno, Maria Pilar, MD, PhD</creator><creator>Alvarez-Cuesta, Emilio, MD, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150401</creationdate><title>Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations</title><author>Ureña-Tavera, Alicia, MD ; Zamora-Verduga, Miriam, MD ; Madrigal-Burgaleta, Ricardo, MD ; Angel-Pereira, Denisse, MD ; Berges-Gimeno, Maria Pilar, MD, PhD ; Alvarez-Cuesta, Emilio, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-98aa49171637cde589bb72eec585645d55cb4498bfb8af085e4b26371b334dd23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acids</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Allergy and Immunology</topic><topic>Antineoplastic Combined Chemotherapy Protocols - adverse effects</topic><topic>Back pain</topic><topic>Calcium</topic><topic>Camptothecin - adverse effects</topic><topic>Camptothecin - analogs &amp; derivatives</topic><topic>Chemotherapy</topic><topic>Colorectal cancer</topic><topic>Drug dosages</topic><topic>Drug Hypersensitivity - diagnosis</topic><topic>Drug Hypersensitivity - immunology</topic><topic>Female</topic><topic>Fluorouracil - adverse effects</topic><topic>Humans</topic><topic>Leucovorin - administration &amp; dosage</topic><topic>Leucovorin - adverse effects</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Neoplasms - complications</topic><topic>Neoplasms - drug therapy</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Vitamin B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ureña-Tavera, Alicia, MD</creatorcontrib><creatorcontrib>Zamora-Verduga, Miriam, MD</creatorcontrib><creatorcontrib>Madrigal-Burgaleta, Ricardo, MD</creatorcontrib><creatorcontrib>Angel-Pereira, Denisse, MD</creatorcontrib><creatorcontrib>Berges-Gimeno, Maria Pilar, MD, PhD</creatorcontrib><creatorcontrib>Alvarez-Cuesta, Emilio, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ureña-Tavera, Alicia, MD</au><au>Zamora-Verduga, Miriam, MD</au><au>Madrigal-Burgaleta, Ricardo, MD</au><au>Angel-Pereira, Denisse, MD</au><au>Berges-Gimeno, Maria Pilar, MD, PhD</au><au>Alvarez-Cuesta, Emilio, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>135</volume><issue>4</issue><spage>1066</spage><epage>1067</epage><pages>1066-1067</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>[...]case: 66-year-old woman, stage IV colon adenocarcinoma, FOLFOX treatment. [...]we describe an important number of confirmed HSRs to leucovorin during a 1-year period.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25457996</pmid><doi>10.1016/j.jaci.2014.09.045</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2015-04, Vol.135 (4), p.1066-1067
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_1668313601
source MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals
subjects Acids
Aged
Aged, 80 and over
Allergy and Immunology
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Back pain
Calcium
Camptothecin - adverse effects
Camptothecin - analogs & derivatives
Chemotherapy
Colorectal cancer
Drug dosages
Drug Hypersensitivity - diagnosis
Drug Hypersensitivity - immunology
Female
Fluorouracil - adverse effects
Humans
Leucovorin - administration & dosage
Leucovorin - adverse effects
Male
Medical treatment
Neoplasms - complications
Neoplasms - drug therapy
Organoplatinum Compounds - adverse effects
Vitamin B
title Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A59%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypersensitivity%20reactions%20to%20racemic%20calcium%20folinate%20(leucovorin)%20during%20FOLFOX%20and%20FOLFIRI%20chemotherapy%20administrations&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Ure%C3%B1a-Tavera,%20Alicia,%20MD&rft.date=2015-04-01&rft.volume=135&rft.issue=4&rft.spage=1066&rft.epage=1067&rft.pages=1066-1067&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2014.09.045&rft_dat=%3Cproquest_cross%3E3643025871%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1668313601&rft_id=info:pmid/25457996&rft_els_id=1_s2_0_S0091674914014316&rfr_iscdi=true